advertisement
CNS and Neurological Disorders - Drug Targets 5
Showing records 1 to 5 | Display only abstracts in CNS and Neurological Disorders - Drug Targets from IGR 22-396508 Melatonin Alleviates Pyroptosis of Retinal Neurons Following Acute Intraocular Hypertension
Huang Y; Guo L; Zhang Y; Zhao M; Xue F; Tan C; Huang J; Chen D
CNS and Neurological Disorders - Drug Targets 2021; 20: 285-297 (IGR: 22-3)
67236 Brain: The Potential Diagnostic and Therapeutic Target for Glaucoma
Faiq MA; Dada R; Kumar A; Saluja D; Dada T
CNS and Neurological Disorders - Drug Targets 2016; 0: (IGR: 17-4)
65952 Rabbit models of ocular diseases: new relevance for classical approaches
Zernii EY; Baksheeva VE; Iomdina EN; Averina OA; Permyakov SE; Philippov PP; Zamyatnin AA; Senin II
CNS and Neurological Disorders - Drug Targets 2015; 0: (IGR: 17-3)
21668 Neuroprotection in glaucoma using calpain-1 inhibitors: Regional differences in calpain-1 activity in the trabecular meshwork, optic nerve and implications for therepeutics
Govindarajan B; Laird J; Sherman R; Salomon RG; Bhattacharya SK
CNS and Neurological Disorders - Drug Targets 2008; 7: 295-304 (IGR: 10-3)
19434 Therapeutic potential of 3-hydroxy-3-methylglutaryl coenzyme a reductase inhibitors for the treatment of retinal and eye diseases
Schmeer C; Kretz A; Isenmann S
CNS and Neurological Disorders - Drug Targets 2007; 6: 282-287 (IGR: 9-3)
